BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18456723)

  • 1. Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation.
    Bébarová M; O'Hara T; Geelen JL; Jongbloed RJ; Timmermans C; Arens YH; Rodriguez LM; Rudy Y; Volders PG
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H48-58. PubMed ID: 18456723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complexity of genotype-phenotype relations associated with loss-of-function sodium channel mutations and the role of in silico studies.
    Wilde AA; Coronel R
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H8-9. PubMed ID: 18502906
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of right precordial ST-segment elevation in structural heart disease: excitation failure by current-to-load mismatch.
    Hoogendijk MG; Potse M; Linnenbank AC; Verkerk AO; den Ruijter HM; van Amersfoorth SC; Klaver EC; Beekman L; Bezzina CR; Postema PG; Tan HL; Reimer AG; van der Wal AC; Ten Harkel AD; Dalinghaus M; Vinet A; Wilde AA; de Bakker JM; Coronel R
    Heart Rhythm; 2010; 7(2):238-48. PubMed ID: 20022821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and mechanisms of action of novel NaV1.5 channel mutations associated with Brugada syndrome.
    Calloe K; Refaat MM; Grubb S; Wojciak J; Campagna J; Thomsen NM; Nussbaum RL; Scheinman MM; Schmitt N
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):177-84. PubMed ID: 23424222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.
    Yan GX; Antzelevitch C
    Circulation; 1999 Oct; 100(15):1660-6. PubMed ID: 10517739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
    Antzelevitch C; Yan GX; Shimizu W
    J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.
    Minoura Y; Di Diego JM; Barajas-Martínez H; Zygmunt AC; Hu D; Sicouri S; Antzelevitch C
    J Cardiovasc Electrophysiol; 2012 Apr; 23(4):423-32. PubMed ID: 22034916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
    Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
    Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease.
    Zhang ZS; Tranquillo J; Neplioueva V; Bursac N; Grant AO
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H399-407. PubMed ID: 16877553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium.
    Remme CA; Verkerk AO; Hoogaars WM; Aanhaanen WT; Scicluna BP; Annink C; van den Hoff MJ; Wilde AA; van Veen TA; Veldkamp MW; de Bakker JM; Christoffels VM; Bezzina CR
    Basic Res Cardiol; 2009 Sep; 104(5):511-22. PubMed ID: 19255801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutations.
    Hsueh CH; Chen WP; Lin JL; Tsai CT; Liu YB; Juang JM; Tsao HM; Su MJ; Lai LP
    J Biomed Sci; 2009 Feb; 16(1):23. PubMed ID: 19272188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain-of-function KCNH2 mutations in patients with Brugada syndrome.
    Wang QI; Ohno S; Ding WG; Fukuyama M; Miyamoto A; Itoh H; Makiyama T; Wu J; Bai J; Hasegawa K; Shinohara T; Takahashi N; Shimizu A; Matsuura H; Horie M
    J Cardiovasc Electrophysiol; 2014 May; 25(5):522-530. PubMed ID: 24400717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel SCN5A mutations in two families with "Brugada-like" ST elevation in the inferior leads and conduction disturbances.
    Maury P; Moreau A; Hidden-Lucet F; Leenhardt A; Fressart V; Berthet M; Denjoy I; Bennamar N; Rollin A; Cardin C; Guicheney P; Chahine M
    J Interv Card Electrophysiol; 2013 Aug; 37(2):131-40. PubMed ID: 23612926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome.
    Kurita T; Shimizu W; Inagaki M; Suyama K; Taguchi A; Satomi K; Aihara N; Kamakura S; Kobayashi J; Kosakai Y
    J Am Coll Cardiol; 2002 Jul; 40(2):330-4. PubMed ID: 12106940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal interventricular differences in tissue architecture underlie right ventricular susceptibility to conduction abnormalities in a mouse model of Brugada syndrome.
    Kelly A; Salerno S; Connolly A; Bishop M; Charpentier F; Stølen T; Smith GL
    Cardiovasc Res; 2018 Apr; 114(5):724-736. PubMed ID: 29267949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delay in right ventricular activation contributes to Brugada syndrome.
    Tukkie R; Sogaard P; Vleugels J; de Groot IK; Wilde AA; Tan HL
    Circulation; 2004 Mar; 109(10):1272-7. PubMed ID: 14993143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventricular differences in sodium current and its potential role in Brugada syndrome.
    Calloe K; Aistrup GL; Di Diego JM; Goodrow RJ; Treat JA; Cordeiro JM
    Physiol Rep; 2018 Jul; 6(14):e13787. PubMed ID: 30009404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.